MOVE Medacta Group

EQS-News: Medacta Launches M.U.S.T. 2.0 Instrumentation to Expand its Offerings for Spine Pathologies

EQS-News: Medacta Launches M.U.S.T. 2.0 Instrumentation to Expand its Offerings for Spine Pathologies
EN
13/10/2020

Underlying

MOVEMedacta Group

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medacta Group

Maria Vara ... (+3)
  • Maria Vara
  • Oscar Haffen Lamm
  • Valliant Campagne
IPH Innate Pharma S...
VLS VALNEVA SE ... (+6)

Suspension of coverage

From 2nd of June we are suspending coverage of companies below due to a reallocation of resources. Our prior estimates should no longer be used as an indicator for the company moving forward.INNATE PHARMAINVENTIVAMEDACTAMEDARTISONWARD MEDICALVALNEVA

IPH INNATE PHARMA SA CLASS A
VLS VALNEVA SE
MED MEDARTIS AG
MOVE MEDACTA GROUP
IVA INVENTIVA ADS
ONWD ONWARD OPPORTUNITIES LIMITED
05/30/25 May 30, 2025 1 EN
Maria Vara
  • Maria Vara
MOVE MEDACTA GROUP

Medacta: model update - Buy rating reiterated, unchanged CHF160 PT

We update our model following the publication of the company's annual report. No changes have been applied to our revenue forecast as FY 2024 results and 2025 guidance are aligned with our estimates. On the P&L, we have softened our S&M expenses expectation as these stood more towards 35.5%

04/30/25 April 30, 2025 1 EN
 PRESS RELEASE
Free
MOVE MEDACTA GROUP

Medacta publishes 2025 Annual General Meeting invitation

Medacta Group SA / Key word(s): AGMEGM Medacta publishes 2025 Annual General Meeting invitation 08.04.2025 / 10:00 CET/CEST Press Release                     Medacta publishes 2025 Annual General Meeting invitation  CASTEL SAN PIETRO, 8 April 2025 – Medacta Group SA (“Medacta”, SIX:MOVE) published today the invitation to the Annual General Meeting (“AGM”) which will take place on Wednesday, 7 May 2025 at 11.00 a.m. at the Group premises in Via alla Rossa 6, Rancate, Switzerland. Shareholders can register to attend the Annual General Meeting in person but will also be abl...

April 8, 2025 1 EN
Maria Vara
  • Maria Vara
MOVE MEDACTA GROUP

Medacta: Exceptional FY2024 to fuel sustainable growth, adj. EBITDA hi...

Medacta reported preliminary unaudited FY 2024 revenue in early February; hence, the EUR590.6m figure was not a surprise. Nonetheless, we may highlight again that all four business lines delivered above the market growth with double-digit cc gains with a broad base geographical contribution. Gross

03/25/25 March 25, 2025 1 EN
Maria Vara
  • Maria Vara
MOVE MEDACTA GROUP

Medacta: expanding SportsMed footprint with Parcus Medical acquisition

Medacta expands its SportMeds footprint by acquiring Parcus Medical, a distinguished player with a diverse product family in sports medicine spanning the shoulder, knee, hip, and foot & ankle, with FY2024 unaudited revenues of USD16m. The acquisition not only expands Medacta's offering but also

03/07/25 March 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch